Trial: 201907039

Randomized Clinical Trial of RANKL Inhibition with Denosumab on Mammographic Density in High Risk Premenopausal Women with Dense Breasts

Phase

II

Principal Investigator

Toriola, Adetunji

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov